Thomas G. Wiggans, Chief Executive Officer at PARDES BIOSCIENCES, INC. (PRDS), bought 12,500 shares at $1.09 ($14K) on 2022-12-05, disclosed to the SEC on 2022-12-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| JSPR | BUY | 2023-11-22 | $6K | — | Filing → |
| JSPR | BUY | 2023-11-20 | $18K | — | Filing → |
| PRDS | BUY | 2022-12-05 | $39K | — | Filing → |